If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

  • This share is currently suspended. It was suspended at a price of 0.25
  • There is currently no data for TLY

Intention to Appoint Administrators and Suspension

6 Jun 2025 13:00

RNS Number : 8472L
Totally PLC
06 June 2025
 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018 ("UK MAR"). With the publication of this announcement, this information is now considered to be in the public domain. 

Totally plc

 

("Totally " or the "Company")

 

Intention to Appoint Administrators of Parent Company and Suspension of Trading in Shares

 

Further to the announcements made on 1 May and 23 May 2025, the Company announces that the Strategic Review being conducted has not produced any solvent offers for Totally, being the parent company of the Totally group of companies (the "Group"), despite a concerted effort by the Company supported by Ernst & Young ("EY"). For the avoidance of doubt, this announcement relates only to Totally Plc, and all businesses within the Group will continue to serve patients as normal. A further announcement will be made in relation to the sale processes for these entities in due course.

 

The Board of Totally has resolved to file a notice of intention to appoint Tim Vance and Sam Woodward as Joint Administrators of Totally Plc today. The Directors are taking this action to protect the interests of the Totally Plc's creditors.

 

In light of the above, the Board announces that it has requested a suspension of trading in the Company's ordinary shares on AIM with immediate effect.

 

This announcement relates solely to the intention to appoint an administrator over the parent company, Totally Plc, and not to any of the trading subsidiaries within the Group.

 

Resignation of Nominated Adviser and Broker

 

As a result of the Company's intention to appoint Administrators, Canaccord Genuity Limited has informed the Company of its resignation as Nominated Adviser and Broker to the Company with immediate effect. Pursuant to AIM Rule 1, if a replacement Nominated Adviser is not appointed within one month from the resignation of the current Nominated Adviser, the admission of the Company's shares to trading on AIM will be cancelled. The Company has no current intention of appointing a replacement Nominated Adviser.

 

For further information please contact:

 

Totally plc

Simon Stilwell, Chair

Prasad Godbole, Chief Executive Officer (Interim)

 

020 3866 3330

Canaccord Genuity Limited (Nominated Adviser & Corporate Broker)

Bobbie Hilliam / Harry Rees

 

020 7523 8000

Ernst & Young

Tim Vance, Partner

0113 298 2410

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURUNUARVNUNRAR
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - Totally Plc
9th Jun 20257:00 amRNSAdministration and Director Resignations
6th Jun 20251:00 pmRNSIntention to Appoint Administrators and Suspension
6th Jun 20251:00 pmRNSSuspension - Totally plc
30th May 20252:25 pmRNSHolding(s) in Company
29th May 20252:10 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSUpdate on Strategic Review
2nd May 20257:00 amRNSHolding(s) in Company
1st May 20257:00 amRNSCommencement of Strategic Review
1st May 20257:00 amRNSTrading Update
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20253:35 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20253:15 pmRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSContract Renewals
26th Feb 20251:00 pmRNSHolding(s) in Company
25th Feb 20256:00 pmRNSHolding(s) in Company
25th Feb 202511:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirectorate Change
20th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20257:00 amRNSOutlook Update
13th Jan 20257:00 amRNSDirectorate Change
7th Jan 20254:15 pmRNSHolding(s) in Company
3rd Dec 20244:00 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSInterim Results
5th Nov 20245:00 pmRNSHolding(s) in Company
31st Oct 20247:00 amRNSUpdate on Banking Facility
17th Oct 20247:00 amRNSNotice of Interim Results & Investor Presentation
27th Sep 20245:45 pmRNSResult of AGM
27th Sep 20249:00 amRNSAGM Statement
27th Sep 20247:00 amRNSContract Win and Extension
20th Sep 20242:30 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20241:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20247:00 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSContract Wins
27th Aug 20246:16 pmRNSHolding(s) in Company
27th Aug 20246:13 pmRNSHolding(s) in Company
2nd Aug 20249:30 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSDirectorate Change
1st Aug 202410:45 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSContract extensions and win
22nd Jul 20243:30 pmRNSHolding(s) in Company
18th Jul 20247:00 amRNSNotice of Results
11th Jul 20247:00 amRNSContract extensions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.